1. OC.02.1 PANCREATIC STELLATE CELLS PROMOTE PLURIPOTENCY IN PANCREATIC CANCER BY PEPTIDYL ARGININE DEIMINASE 4 (PADI4) INDUCED CITRULLINATION: A NEW TARGET FOR PANCREATIC CANCER THERAPY. (25th March 2019) Authors: Picariello, L.; Dragoni, G.; Grappone, C.; Polvani, S.; Lapenna, L.; Casini, N.; Galli, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC.10.8 DISHEVELLED-ASSOCIATED ANTAGONIST OF B-CATENIN 2 (DACT2) IN PANCREATIC DUCTAL ADENOCARCINOMA. (September 2021) Authors: Polvani, S.; Ceni, E.; Mello, T.; Tarocchi, M.; Simeone, I.; Guida, A.; Dragoni, G.; Picariello, L.; Grappone, C.; Milani, S.; Galli, A. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER. (March 2023) Authors: Polvani, S.; Mello, T.; Ceni, E.; Guida, A.; Picariello, L.; Grappone, C.; Dragoni, G.; Lynch, E.N.; Innocenti, T.; Tarocchi, M.; Donati, C.; Bruni, P.; Milani, S.; Galli, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗